theophylline and olaparib

theophylline has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Backes, FJ; Banerjee, A; Cai, S; Chakravarti, A; Cui, T; Han, C; Liu, L; McLaughlin, E; Wang, QE; Wu, D; Xie, G; Yin, M; Zhang, J; Zhang, X; Zheng, Y	1

Other Studies

1 other study(ies) available for theophylline and olaparib

Article	Year
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2 Molecular cancer therapeutics, 2020, Volume: 19, Issue:1 Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Cell Cycle Proteins; Cell Line, Tumor; DNA End-Joining Repair; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Mutation; Nuclear Proteins; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Retinal Dehydrogenase; Theophylline; Transcription Factors; Transfection; Xenograft Model Antitumor Assays	2020

Article

Year

ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2

Molecular cancer therapeutics, 2020, Volume: 19, Issue:1

Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carcinoma, Ovarian Epithelial; Cell Cycle Proteins; Cell Line, Tumor; DNA End-Joining Repair; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Mutation; Nuclear Proteins; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Retinal Dehydrogenase; Theophylline; Transcription Factors; Transfection; Xenograft Model Antitumor Assays

2020